Works matching AU Kawamura, Hayato

Results: 16

Poor Tolerability of Lenvatinib in Elderly Patients with Advanced Hepatocellular Carcinoma after Disease Progression following First-Line Atezolizumab Plus Bevacizumab: A Multicenter Study.

Published in:

Oncology, 2025, v. 103, n. 4, p. 311, doi. 10.1159/000541455

By:

Kato, Daisuke;
Suzuki, Takanori;
Matsuura, Kentaro;
Okayama, Kohei;
Okumura, Fumihiro;
Nagura, Yoshihito;
Sobue, Satoshi;
Hayashi, Katsumi;
Kusakabe, Atsunori;
Hasegawa, Izumi;
Matoya, Sho;
Mizoshita, Tsutomu;
Kimura, Yoshihide;
Kondo, Hiromu;
Ozasa, Atsushi;
Kawamura, Hayato;
Fujiwara, Kei;
Nojiri, Shunsuke;
Kataoka, Hiromi

Publication type:

Article

Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study.

Published in:

Oncology, 2024, v. 102, n. 8, p. 676, doi. 10.1159/000536367

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Suzuki, Yuta;
Okumura, Fumihiro;
Nagura, Yoshihito;
Sobue, Satoshi;
Kato, Daisuke;
Kusakabe, Atsunori;
Koguchi, Hiroki;
Hasegawa, Izumi;
Matoya, Sho;
Miyaki, Tomokatsu;
Kimura, Yoshihide;
Tanaka, Yoshito;
Kondo, Hiromu;
Ozasa, Atsushi;
Kawamura, Hayato;
Kuno, Kayoko;
Fujiwara, Kei;
Nojiri, Shunsuke

Publication type:

Article

Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents.

Published in:

Oncology, 2024, v. 102, n. 7, p. 611, doi. 10.1159/000536154

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Nagura, Yoshihito;
Kawamura, Hayato;
Fujiwara, Kei;
Ogawa, Shintaro;
Nagaoka, Katsuya;
Iio, Etsuko;
Watanabe, Takehisa;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Efficacy of Mucosal Cutting Biopsy for the Histopathological Diagnosis of Gastric Submucosal Tumors.

Published in:

Case Reports in Gastroenterology, 2019, v. 13, n. 1, p. 185, doi. 10.1159/000499442

By:

Adachi, Akihisa;
Hirata, Yoshikazu;
Kawamura, Hayato;
Harada, Takahito;
Hattori, Reika;
Kumai, Daisuke;
Yamamoto, Yuki;
Kojima, Yuki;
Ikeuchi, Hirokazu;
Hayashi, Noriyuki;
Mochizuki, Hisato;
Takada, Hiroki;
Yamaguchi, Ryuzo;
Sobue, Satoshi

Publication type:

Article

Serum interleukin‐6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis.

Published in:

Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 10, p. 2158, doi. 10.1111/jgh.16672

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Suzuki, Yuta;
Okumura, Fumihiro;
Nagura, Yoshihito;
Sobue, Satoshi;
Matoya, Sho;
Miyaki, Tomokatsu;
Kimura, Yoshihide;
Kusakabe, Atsunori;
Narahara, Satoshi;
Tokunaga, Takayuki;
Nagaoka, Katsuya;
Murakami, Shuko;
Inoue, Takako;
Kuroyanagi, Keita;
Kawamura, Hayato;
Fujiwara, Kei;
Nojiri, Shunsuke;
Kataoka, Hiromi

Publication type:

Article

Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis.

Published in:

Cancer Medicine, 2024, v. 13, n. 1, p. 1, doi. 10.1002/cam4.6876

By:

Takanori Suzuki;
Kentaro Matsuura;
Yuta Suzuki;
Fumihiro Okumura;
Yoshihito Nagura;
Satoshi Sobue;
Sho Matoya;
Tomokatsu Miyaki;
Yoshihide Kimura;
Atsunori Kusakabe;
Satoshi Narahara;
Takayuki Tokunaga;
Katsuya Nagaoka;
Keita Kuroyanagi;
Hayato Kawamura;
Kayoko Kuno;
Kei Fujiwara;
Shunsuke Nojiri;
Hiromi Kataoka;
Yasuhito Tanaka

Publication type:

Article

Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients.

Published in:

Journal of Medical Virology, 2024, v. 96, n. 7, p. 1, doi. 10.1002/jmv.29816

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Inoue, Takako;
Sasada, Keiko;
Ogawa, Shintaro;
Watanabe, Takehisa;
Kawamura, Hayato;
Fujiwara, Kei;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance.

Published in:

Journal of Medical Virology, 2023, v. 95, n. 9, p. 1, doi. 10.1002/jmv.29109

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Watanabe, Takehisa;
Matsui, Takeshi;
Ogawa, Shintaro;
Kawamura, Hayato;
Kuno, Kayoko;
Fujiwara, Kei;
Nojiri, Shunsuke;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Neutrophil‐to‐lymphocyte ratio at the start of the second course of durvalumab plus tremelimumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

Published in:

Hepatology Research, 2025, v. 55, n. 6, p. 883, doi. 10.1111/hepr.14189

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Sobue, Satoshi;
Kato, Daisuke;
Hayashi, Katsumi;
Kondo, Hiromu;
Anbe, Kaiki;
Mizoshita, Tsutomu;
Okayama, Kohei;
Okumura, Fumihiro;
Kimura, Yoshihide;
Ozasa, Atsushi;
Inada, Hiroki;
Tokunaga, Takayuki;
Narahara, Satoshi;
Kawamura, Hayato;
Fujiwara, Kei;
Nojiri, Shunsuke;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Factors associated with low hepatitis B surface antigen levels in chronic hepatitis B patients treated with nucleot(s)ide analogs.

Published in:

Hepatology Research, 2025, v. 55, n. 3, p. 309, doi. 10.1111/hepr.14129

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Inoue, Takako;
Kawamura, Hayato;
Fujiwara, Kei;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Efficacy of antiviral therapy for the prevention of mother‐to‐child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy.

Published in:

Hepatology Research, 2024, v. 54, n. 11, p. 1106, doi. 10.1111/hepr.14048

By:

Kawamura, Hayato;
Matsuura, Kentaro;
Ito, Koichi;
Sugiura, Tokio;
Suzuki, Takanori;
Fujiwara, Kei;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

Serum inducible protein 10 kDa/C‐X‐C motif chemokine 10 levels predict regression of M2BPGi‐based liver fibrosis after hepatitis C virus eradication by direct‐acting antiviral agents.

Published in:

Hepatology Research, 2024, v. 54, n. 1, p. 32, doi. 10.1111/hepr.13962

By:

Nagura, Yoshihito;
Suzuki, Takanori;
Matsuura, Kentaro;
Ogawa, Shintaro;
Kawamura, Hayato;
Kuno, Kayoko;
Fujiwara, Kei;
Nojiri, Shunsuke;
Nagaoka, Katsuya;
Iio, Etsuko;
Watanabe, Takehisa;
Kataoka, Hiromi;
Tanaka, Yasuhito

Publication type:

Article

The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.

Published in:

Hepatology Research, 2023, v. 53, n. 6, p. 511, doi. 10.1111/hepr.13886

By:

Matoya, Sho;
Suzuki, Takanori;
Matsuura, Kentaro;
Suzuki, Yuta;
Okumura, Fumihiro;
Nagura, Yoshihito;
Sobue, Satoshi;
Kuroyanagi, Keita;
Kusakabe, Atsunori;
Koguchi, Hiroki;
Hasegawa, Izumi;
Miyaki, Tomokatsu;
Tanaka, Yoshito;
Kondo, Hiromu;
Kimura, Yoshihide;
Ozasa, Atsushi;
Kawamura, Hayato;
Kuno, Kayoko;
Fujiwara, Kei;
Nojiri, Shunsuke

Publication type:

Article

Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.

Published in:

Hepatology Research, 2023, v. 53, n. 4, p. 289, doi. 10.1111/hepr.13864

By:

Suzuki, Takanori;
Matsuura, Kentaro;
Urakabe, Kenji;
Okumura, Fumihiro;
Kawamura, Hayato;
Sobue, Satoshi;
Matoya, Sho;
Miyaki, Tomokatsu;
Kimura, Yoshihide;
Kato, Daisuke;
Kusakabe, Atsunori;
Tanaka, Yoshito;
Ozasa, Atsushi;
Nagura, Yoshihito;
Fujiwara, Kei;
Nojiri, Shunsuke;
Hagiwara, Shinya;
Kusumoto, Shigeru;
Inoue, Takako;
Tanaka, Yasuhito

Publication type:

Article

Adult-onset Still's Disease (AOSD) with Gastrointestinal Lesions.

Published in:

Internal Medicine, 2024, v. 63, n. 24, p. 3317, doi. 10.2169/internalmedicine.3412-23

By:

Takahito Harada;
Yoshikazu Hirata;
Hayato Kawamura;
Yuki Yamamoto;
Yuka Kobayashi;
Daisuke Kumai;
Akihisa Adachi;
Yoshihito Nagura;
Hirokazu Ikeuchi;
Noriyuki Hayashi;
Hiroki Takada;
Satoshi Sobue;
Megumi Yoshida

Publication type:

Article

Adult-onset Type II Citrullinemia Developed under Dietary Restrictions during Imprisonment.

Published in:

Internal Medicine, 2024, v. 63, n. 6, p. 833, doi. 10.2169/internalmedicine.1954-23

By:

Takanori Suzuki;
Kentaro Matsuura;
Naoto Imura;
Hayato Kawamura;
Kayoko Kuno;
Kei Fujiwara;
Shunsuke Nojiri;
Shogo Ito;
Takao Togawa;
Hiromi Kataoka

Publication type:

Article